Your browser doesn't support javascript.
loading
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
Steimlé, Thomas; Dourthe, Marie-Emilie; Alcantara, Marion; Touzart, Aurore; Simonin, Mathieu; Mondesir, Johanna; Lhermitte, Ludovic; Bond, Jonathan; Graux, Carlos; Grardel, Nathalie; Cayuela, Jean-Michel; Arnoux, Isabelle; Gandemer, Virginie; Balsat, Marie; Vey, Norbert; Macintyre, Elizabeth; Ifrah, Norbert; Dombret, Hervé; Petit, Arnaud; Baruchel, André; Ruminy, Philippe; Boissel, Nicolas; Asnafi, Vahid.
Afiliación
  • Steimlé T; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Dourthe ME; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Alcantara M; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital (AP-HP), Université de Paris, Paris, France.
  • Touzart A; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Simonin M; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital (AP-HP), Université de Paris, Paris, France.
  • Mondesir J; Center for Cancer Immunotherapy, INSERM U932, Institut Curie, PSL Research University, Paris, France.
  • Lhermitte L; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Bond J; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Graux C; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital (AP-HP), Université de Paris, Paris, France.
  • Grardel N; Center for Cancer Immunotherapy, INSERM U932, Institut Curie, PSL Research University, Paris, France.
  • Cayuela JM; Department of Pediatric Hematology and Oncology, Assistance Publique-Hôpitaux de Paris (AP-HP), GH HUEP, Armand Trousseau Hospital, Paris, France.
  • Arnoux I; Sorbonne Universités, UPMC Univ Paris 06, UMRS 938, CDR Saint-Antoine, GRC n°07, GRC MyPAC, Paris, France.
  • Gandemer V; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Balsat M; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Vey N; Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.
  • Macintyre E; Department of Hematology, Université catholique de Louvain, CHU UCL Namur - site Godinne, Yvoir, Belgium.
  • Ifrah N; Laboratory of Hematology, CHRU Lille, Lille, France and U1172, INSERM, Lille, France.
  • Dombret H; Laboratory of Hematology and EA 3518 University Hospital Saint-Louis, AP-HP and Université de Paris, Paris, France.
  • Petit A; Hematology Laboratory, Marseille University Hospital Timone, Marseille, France.
  • Baruchel A; Department of Pediatric Hematology and Oncology, University Hospital of Rennes, Rennes, France.
  • Ruminy P; Service d'hématologie clinique, Hôpital Lyon Sud, Marseille, France.
  • Boissel N; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.
  • Asnafi V; Université de Paris (Descartes), Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
Blood Cancer J ; 12(1): 14, 2022 01 26.
Article en En | MEDLINE | ID: mdl-35082269
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fusión Oncogénica / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fusión Oncogénica / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos